245 related articles for article (PubMed ID: 7912544)
1. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
Rhodes T; Barrand MA; Twentyman PR
Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
[TBL] [Abstract][Full Text] [Related]
2. Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpression.
Coley HM; Workman P; Twentyman PR
Br J Cancer; 1991 Mar; 63(3):351-7. PubMed ID: 1672252
[TBL] [Abstract][Full Text] [Related]
3. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
4. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines.
Coley HM; Amos WB; Twentyman PR; Workman P
Br J Cancer; 1993 Jun; 67(6):1316-23. PubMed ID: 8099807
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis and biological properties of novel fluorescent antifolates in Pgp- and MRP-overexpressing tumour cell lines.
Robson C; Wright KA; Twentyman PR; Lambert PA; Griffin RJ
Biochem Pharmacol; 1998 Oct; 56(7):807-16. PubMed ID: 9774142
[TBL] [Abstract][Full Text] [Related]
6. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
7. Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells.
Marquardt D; Center MS
J Natl Cancer Inst; 1991 Aug; 83(15):1098-102. PubMed ID: 1831509
[TBL] [Abstract][Full Text] [Related]
8. Characterization of H+-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells.
Benderra Z; Morjani H; Trussardi A; Manfait M
Leukemia; 1998 Oct; 12(10):1539-44. PubMed ID: 9766497
[TBL] [Abstract][Full Text] [Related]
9. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
[TBL] [Abstract][Full Text] [Related]
10. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
Lehne G; De Angelis P; Clausen OP; Rugstad HE
Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
[TBL] [Abstract][Full Text] [Related]
11. Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.
Verovski VN; Van den Berge DL; Delvaeye MM; Scheper RJ; De Neve WJ; Storme GA
Br J Cancer; 1996 Mar; 73(5):596-602. PubMed ID: 8605092
[TBL] [Abstract][Full Text] [Related]
12. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
[TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
Michieli M; Michelutti A; Damiani D; Pipan C; Raspadori D; Lauria F; Baccarani M
Leuk Lymphoma; 1993 Feb; 9(3):255-64. PubMed ID: 8097129
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
15. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
16. Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
Schuurhuis GJ; Broxterman HJ; de Lange JH; Pinedo HM; van Heijningen TH; Kuiper CM; Scheffer GL; Scheper RJ; van Kalken CK; Baak JP
Br J Cancer; 1991 Nov; 64(5):857-61. PubMed ID: 1681887
[TBL] [Abstract][Full Text] [Related]
17. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
[TBL] [Abstract][Full Text] [Related]
18. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
19. Monensin and verapamil do not alter intracellular localisation of daunorubicin in multidrug resistant human KB cells.
Wood DJ; Rumsby MG; Warr JR
Cancer Lett; 1996 Nov; 108(1):41-7. PubMed ID: 8950207
[TBL] [Abstract][Full Text] [Related]
20. Modulation by acrolein and chloroacetaldehyde of multidrug resistance mediated by the multidrug resistance-associated protein (MRP).
Manzano RG; Wright KA; Twentyman PR
Clin Cancer Res; 1996 Aug; 2(8):1321-6. PubMed ID: 9816303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]